A liquid chromatographic-electrospray-tandem mass spectrometric method for quantitation of quetiapine in human plasma and liver microsomes: Application to a study of in vitro metabolism

Journal of Analytical Toxicology

Volumn 28, Issue 6, 2004, Pages 443-448

  Lin, Shen Nan ^a   Chang, Yan ^a   Moody, David E ^a   Foltz, Rodger L ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOYLECGONINE; BUPRENORPHINE; CLOZAPINE; COCAINE; COMPLEMENTARY DNA; CYTOCHROME P450 2D6; CYTOCHROME P450 3A4; ECGONINE METHYL ESTER; METHADONE; MORPHINE; NEUROLEPTIC AGENT; NORBUPRENORPHINE; QUETIAPINE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL CELL; CHROMATOGRAPHY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG BLOOD LEVEL; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LIQUID CHROMATOGRAPHY; LIVER MICROSOME; MASS SPECTROMETRY; MENTAL DISEASE; MICROSOME; NONHUMAN; PLASMA; PSYCHOPHARMACOTHERAPY; SCHIZOPHRENIA; SOMNOLENCE; TANDEM MASS SPECTROMETRY;

ANIMALIA;

EID: 4344664426     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/28.6.443     Document Type: Conference Paper

References (14)

1. S.M. Cheer and A.J. Wagstuff. Quetiapine: a review of its use in the management of schizophrenia. CNS Drugs 18: 173-199 (2004).
2. K.L. Sloan, V.M. Haver, and A.J. Saxon. Quetiapine and false-positive urine drug testing for tricyclic antidepressants. Am J. Psychiatry 157: 148-149 (2000).
3. C.L. DeVane and C.B. Nemeroff. Clinical pharmacokinetics of quetiapine: an atypical antipsychotic. Clin. Pharmacokinet. 40: 510-522 (2001).
4. S.W. Grimm, K.R. Stams, and K. Bui. In vitro prediction of potential metabolic drug interaction for Seroquel. Abstract. Schizophr. Res. 24: 200 (1997).
5. Y.W.J. Wang, C. Yeh, and P.T. Thyrum. The effects of concomitant phenytoin administration on the steady state pharmacokinetics of quetiapine. J. Clin. Psychopharmacol. 21: 89-93 (2001).
6. S.G. Potkin, P.T. Thyrum, G. Alva, R. Bera, C. Yeh, and L.A. Arvanitis. The safety and pharmacokineties of quetiapine when coadministered with haloperidol, risperidone or thioridazine. J. Clin. Psychopharmacol. 22: 121-130 (2002).
7. S.M. Strakowski, P.E.J. Kech, Jr., and Y.W.J. Wang. The effects of multiple doses of cimetidine on the steady-state pharmacokinetics of quetiapine in men with selected psychotic disorders. J. Clin. Psychopharmacol. 22: 201-205 (2002).
8. J. Hasselstrom and K. Linnet. Fully automated on-line quantification of quetiapine in human serum by solid phase extraction and liquid chromatography. J. Chromatogr. B 798: 9-16 (2003)
9. R.H. Pullen, D.M. Palermo, and M.A. Curtis. Determination of an antipsychotic agent (ICI 204,636) and its 7-hydroxy metabolite in human plasma by high performance liquid chromatography and gas chromatography-mass spectrometry. J. Chromatogr. 573: 49-57 (1992).
10. P.C. Davis, J. Wang, and O. Gefvert. Analysis and pharmacokinetics of quetiapine and two metabolites in human plasma using reversed-phase HPLC with ultraviolet and electrochemical detection. J. Pharm. Biomed Anal. 20: 271-282 (1999).
11. R. Nabdruiku, S. Fanali, A. Ferranti, and M.A. Raggi. HPLC analysis of the novel antipsychotic drug quetiapine in human plasma. J. Pharm. Biomed. Anal. 30: 969-977 (2002).
12. K.-Y. Li, Z.-N. Cheng, X. Li, X.-L. Bai, B.-K. Zhang, F. Wang, and H.-D. Li. Simultaneous determination of quetiapine and three metabolites in human plasma by high-performance liquid chromatography-electrospray ionization mass spectrometry. Acta. Pharmacol. Sin. 25: 110-114 (2004).
13. A.C. Nelson, W. Huang, and D.E. Moody. Variables in human liver microsome preparation: impact on the kinetics of I-α-acetylmethadol (LAAM) N-demethylation and dextromethorphan-demethylation. Drug Metab. Dispos. 29: 319-325 (2001).
14. D.E. Moody, M.H. Slawson, E.C. Strain, J.D. Laycock, A.C. Spanbauer, and R.L. Foltz. A liquid chromatographic-electrospray ionization-tandem mass spectrometric method for determination of buprenorphine, its metabolite norbuprenorphine and a coformulant, naloxone, that is suitable for in vivo and in vitro metabolism studies. Anal. Biochem. 306: 31-39 (2002).